“Two-phase”的搜索结果，显示 61-70 项，共有 3077 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

2. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. A Phase 1b/2, open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18 ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

6. 血液科- 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Phase 1b/2, open label, multi-center, clinical ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Open-label, Multi-center, Phase 1b/2 ... Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential ...